IRIS

Group A2 Analogs of Innovator Teicoplanin: Variability of their Ratio during Treatment Time Course in Human Blood; Consequences for the Generics / F., Jehl; Schramm, F; A., Brink; Colombo, Paolo. - In: PHARMACEUTICAL REGULATORY AFFAIRS. - ISSN 2167-7689. - 02:(2013). [10.4172/2167-7689.1000112]

Group A2 Analogs of Innovator Teicoplanin: Variability of their Ratio during Treatment Time Course in Human Blood; Consequences for the Generics

COLOMBO, Paolo
2013-01-01
2013
Group A2 Analogs of Innovator Teicoplanin: Variability of their Ratio during Treatment Time Course in Human Blood; Consequences for the Generics / F., Jehl; Schramm, F; A., Brink; Colombo, Paolo. - In: PHARMACEUTICAL REGULATORY AFFAIRS. - ISSN 2167-7689. - 02:(2013). [10.4172/2167-7689.1000112]
1.1 Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2742708
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact